Propalin Syrup, 40 mg/ml Dogs – SPC change
Change to the information provided on adverse events in the Summary of Product Characteristics for Propalin Syrup, 40 mg/ml Dogs.
Following monitoring of pharmacovigilance data, the Summary of Product Characteristics (SPC) for Propalin Syrup, 40 mg/ml Dogs has been updated:
-
Sympathomimetics may produce very rarely a wide range of effects, most of which mimic the results of excessive stimulation of the sympathetic nervous system such as effects on heart rate (tachycardia) or effects on blood pressure (increased blood pressure), which can induce proteinuria. Dizziness, decrease in appetite, arrythmia, collapse, aggression, hyperactivity (including restlessness), polydipsia, polyuria, ataxia, seizure and hypersensitivity may occur in very rare cases. Liquid diarrhoea/loose stool, emesis and lethargy have been reported rarely.
-
Due to the very low doses to be administered, and to avoid any risk of overdose, the animal must be weighed, and the recommended doses must be respected.
Any veterinary medicinal product which is authorised for marketing in the United Kingdom will have its Summary of Product Characteristics (SPC) available on our Product Information Database.
No medicine is 100% risk free, the SPC includes information on what adverse events have been known to occur following administration of a particular product, these can be found in either section Adverse events (3.6) or Adverse reactions (4.6).
All updates to SPCs other than template changes, are published in the medicine updates section of VMD Connect.